Industry News
Pharmaceutical Industry News
Life sciences leaders say patient…
Life sciences leaders say patient support is falling short. New research reveals why 9 of the top 10 pharma manufacturers partner with Redi Health.
Novartis is executing more layoffs…
Novartis is executing more layoffs at its U.S. headquarters in East Hanover, New Jersey, handing 322 employees pink slips. The cuts will go into effect by Oct. 2, according to a Worker Adjustment and Retraining
As Bristol Myers Squibb attempts…
As Bristol Myers Squibb attempts to convert two accelerated oncology nods for Krazati into traditional FDA approvals, the company has detailed what could be a major stumble in the KRAS G12C inhibitor’s smaller-opportunity indication of
While not on the same scale of…
While not on the same scale of some of Big Pharma’s major carveouts in recent years, the deal follows a noticeable pattern in which diversified drugmakers have simplified their structures to focus more on innovative
When Vera Therapeutics in-licensed…
When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no FDA-approved treatment options. Today, the dual-target drug has crossed the regulatory finish line but is entering
More Americans Than Ever Are Taking Weight-Loss Drugs
The number of U.S. adults taking an obesity medication has nearly quadrupled from just two years ago.
Vertex Pharmaceuticals has struck…
Vertex Pharmaceuticals has struck a $10 billion deal—its largest ever—to acquire endocrine disease specialist Crinetics Pharmaceuticals. The transaction's two focuses, Palsonify and atumelnant, have combined peak sales potential of more than $5 billion, Vertex said.
Healthcare comms and AI marketing…
Healthcare comms and AI marketing firm Real Chemistry has set up its first Asia Pacific strategic hub in Singapore with the acquisition of Spurwing Communications.
Skin quality affects quality of…
Skin quality affects quality of life for 85% of people, leaving more than one-third of individuals feeling self-conscious, insecure or anxious, a Galderma survey found.
Heidi, alongside creative firm…
Heidi, alongside creative firm Cocogun and media agency TRG, have launched a new brand campaign that positions its AI tool as a dose of "relief, on repeat."
Vertex Pharmaceuticals has gained…
Vertex Pharmaceuticals has gained a label expansion from the FDA, which allows children ages 2 and up to receive the gene therapy Casgevy for the treatment of sickle cell disease or transfusion-dependent beta thalassemia. The
Amgen has issued a voluntary…
Amgen has issued a voluntary recall for nearly 1 million bottles of the heart medication Corlanor (ivabradine) due to possible contamination.
The ad uses hand-crafted puppets…
The ad uses hand-crafted puppets to portray sight-based frustrations for those with presbyopia, a common condition that causes blurry up-close vision.
Contract manufacturing powerhouse…
Contract manufacturing powerhouse Lonza is growing in more ways than one. The Swiss company revealed this week that it is expanding its capacity to manufacture antibody-drug conjugates—and that it has increased the scope of its
After a site visit by FDA…
After a site visit by FDA inspectors yielded a Form 483 for Genzyme Ireland in early 2026, the Sanofi subsidiary is facing further reprimand from the U.S. regulator.
As BridgeBio ramps up for the…
As BridgeBio ramps up for the launch of three new medicines and continues to channel resources into its soon-to-be-blockbuster in ATTR-CM, Attruby, Sixth Street and HealthCare Royalty have agreed to invest up to $1 billion
On a quest to bolster its life-sci…
On a quest to bolster its life-sci contracting bona fides, self-described “multifaceted manufacturer” Kimball Electronics is going down the path of M&A.
Consumer health giant Haleon has…
Consumer health giant Haleon has tapped Microsoft to incorporate AI across its operations, joining a growing wave of healthcare and life sciences heavyweights turning to Big Tech to execute enterprise-wide digital overhauls.
What Older Adults Should Know About GLP-1 Drugs as Medicare Coverage Expands
A Medicare pilot beginning Wednesday will broaden access to medications like Wegovy and Zepbound. There are unique risks for those over 65.
Plus Therapeutics is evolving its…
Plus Therapeutics is evolving its business and has rebranded as Cerenome to reflect its expansion.